All questions are shown as received by the Trust.
1. Do you currently use an electronic prescribing system?
2. If so, who is the supplier and what version of the software do you use?
3. Have you been on the same electronic prescribing system between 01/10/2022 to 01/10/2023?
4. How many allergies have been added to patient records in the system for the drug penicillamine between 01/10/2022 to 01/10/2023?
5. How many of these penicillamine drug allergies were recorded as anaphylaxis?
6. How many allergies have been added to patient records in the system for the drug class penicillins between 01/10/2022 to 01/10/2023?
7. Do you have any mitigations in place to prevent users adding penicillamine drug allergies to patient records in error?
8. Do you report electronic prescribing system incidents to any governing bodies outside of your Trust? (e.g MHRA Yellow Card)
